M.D.C.’s (MDC) “Sell” Rating Reaffirmed at UBS Group
M.D.C. (NYSE:MDC)‘s stock had its “sell” rating reissued by analysts at UBS Group in a report issued on Wednesday, 99wallstreet.com reports. They presently have a $32.00 price target on the construction company’s stock, up from their prior price target of $30.00. UBS Group’s target price would indicate a potential downside of 7.75% from the company’s current price.
Other equities analysts have also issued research reports about the company. ValuEngine lowered M.D.C. from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 2nd. Zacks Investment Research raised M.D.C. from a “sell” rating to a “hold” rating in a report on Wednesday, October 4th. KeyCorp reaffirmed a “hold” rating on shares of M.D.C. in a report on Tuesday, September 26th. Finally, Citigroup dropped their price objective on M.D.C. from $37.00 to $34.00 and set a “neutral” rating on the stock in a report on Friday, November 3rd. Four investment analysts have rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $30.33.
M.D.C. (NYSE:MDC) traded up $1.05 during trading hours on Wednesday, reaching $34.69. The company had a trading volume of 466,111 shares, compared to its average volume of 527,555. The stock has a market capitalization of $1,910.00, a price-to-earnings ratio of 12.48, a PEG ratio of 0.88 and a beta of 1.38. The company has a quick ratio of 2.60, a current ratio of 9.45 and a debt-to-equity ratio of 0.65. M.D.C. has a 52-week low of $25.87 and a 52-week high of $37.45.
In related news, Director Herbert T. Buchwald sold 28,350 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $31.52, for a total transaction of $893,592.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director David Siegel sold 2,500 shares of the firm’s stock in a transaction dated Friday, December 8th. The stock was sold at an average price of $31.83, for a total value of $79,575.00. The disclosure for this sale can be found here. Company insiders own 25.30% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Schwab Charles Investment Management Inc. grew its holdings in shares of M.D.C. by 5.2% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 328,247 shares of the construction company’s stock worth $10,465,000 after buying an additional 16,258 shares during the last quarter. Louisiana State Employees Retirement System grew its holdings in shares of M.D.C. by 14.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 19,300 shares of the construction company’s stock worth $615,000 after buying an additional 2,436 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of M.D.C. by 8.0% during the fourth quarter. Nisa Investment Advisors LLC now owns 34,267 shares of the construction company’s stock worth $1,092,000 after buying an additional 2,537 shares during the last quarter. New England Research & Management Inc. purchased a new position in shares of M.D.C. during the fourth quarter worth about $1,098,000. Finally, Public Employees Retirement System of Ohio grew its holdings in shares of M.D.C. by 368.4% during the third quarter. Public Employees Retirement System of Ohio now owns 17,009 shares of the construction company’s stock worth $565,000 after buying an additional 13,378 shares during the last quarter. 74.15% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: This news story was first published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://www.americanbankingnews.com/2018/01/17/m-d-c-mdc-price-target-increased-to-32-00-by-analysts-at-ubs-group.html.
M.D.C. Company Profile
M.DC Holdings, Inc is engaged in two primary operations, including homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington; Mountain, including segments located in Colorado and Utah; East, including segments located in Virginia, Florida and Maryland, which includes Pennsylvania and New Jersey; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc, StarAmerican Insurance Ltd., American Home Insurance Agency, Inc and American Home Title and Escrow Company.
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.